These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11334224

  • 1. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z, Dziedzicka-Wasylewska M.
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [Abstract] [Full Text] [Related]

  • 2. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z, Skuza G.
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [Abstract] [Full Text] [Related]

  • 3. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J, Dziedzicka-Wasylewska M, Rogoz R, Rogóz Z.
    Eur J Pharmacol; 1998 Jun 12; 351(1):31-7. PubMed ID: 9698202
    [Abstract] [Full Text] [Related]

  • 4. Some behavioural effects of antidepressant drugs are time-dependent.
    Dziedzicka-Wasylewska M, Rogóz Z, Margas W, Dlaboga D, Góralska M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb 12; 25(2):373-93. PubMed ID: 11294483
    [Abstract] [Full Text] [Related]

  • 5. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
    Rogóz Z, Skuza G, Kłlodzińska A.
    Pol J Pharmacol; 2004 Feb 12; 56(5):519-26. PubMed ID: 15591639
    [Abstract] [Full Text] [Related]

  • 6. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I, Sághy K.
    Behav Pharmacol; 2004 Jul 12; 15(4):253-62. PubMed ID: 15252275
    [Abstract] [Full Text] [Related]

  • 7. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C, Biala G, Le Bihan C, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2003 Feb 12; 166(1):19-32. PubMed ID: 12525958
    [Abstract] [Full Text] [Related]

  • 8. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists.
    Kolasiewicz W, Maj J.
    Pol J Pharmacol; 2001 Feb 12; 53(5):509-15. PubMed ID: 11990070
    [Abstract] [Full Text] [Related]

  • 9. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J, Rogóz Z, Skuza G.
    J Neural Transm (Vienna); 1999 Feb 12; 106(11-12):1063-73. PubMed ID: 10651103
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov 12; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

  • 11. Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors.
    Dziedzicka-Wasylewska M, Rogoz Z, Skuza G, Dlaboga D, Maj J.
    Behav Pharmacol; 2002 Mar 12; 13(2):127-38. PubMed ID: 11981225
    [Abstract] [Full Text] [Related]

  • 12. Effect of repeated treatment with milnacipran on the central dopaminergic system.
    Rogóz Z, Margas W, Dlaboga D, Góralska M, Dziedzicka-Wasylewska M, Maj J.
    Pol J Pharmacol; 2000 Mar 12; 52(2):83-92. PubMed ID: 10949109
    [Abstract] [Full Text] [Related]

  • 13. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M, Rogóz Z.
    Pol J Pharmacol; 1997 Mar 12; 49(5):337-43. PubMed ID: 9566033
    [Abstract] [Full Text] [Related]

  • 14. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec 12; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 15. The lack of effect of repeated treatment with antidepressant drugs on the 8-OH-DPAT-induced increase in the serum corticosterone concentration.
    Przegaliński E, Warchoł-Kania A, Budziszewska B.
    Pol J Pharmacol Pharm; 1989 Dec 12; 41(1):63-8. PubMed ID: 2531382
    [Abstract] [Full Text] [Related]

  • 16. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
    Rogoz R, Dziedzicka-Wasylewska M.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar 12; 359(3):178-86. PubMed ID: 10208304
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
    Mattingly BA, Caudill A, Abel M.
    Pharmacol Biochem Behav; 2001 Mar 12; 68(3):417-26. PubMed ID: 11325394
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
    Breuer ME, Groenink L, Oosting RS, Buerger E, Korte M, Ferger B, Olivier B.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):134-40. PubMed ID: 19549514
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
    Maj J, Dziedzicka-Wasylewska M, Rogoz R, Rogóz Z, Skuza G.
    Eur J Pharmacol; 1996 May 23; 304(1-3):49-54. PubMed ID: 8813583
    [Abstract] [Full Text] [Related]

  • 20. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement.
    Parsons LH, Caine SB, Sokoloff P, Schwartz JC, Koob GF, Weiss F.
    J Neurochem; 1996 Sep 23; 67(3):1078-89. PubMed ID: 8752115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.